Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375304
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-12
Brief Title:
The Antiretroviral Speed Access Program Switch ASAP-Switch Study
Sponsor:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Organization:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Study Overview
Official Title:
Antiretroviral Speed Access Program Switch Study The ASAP Switch Study - A Pilot Study to Switch ART-experienced and Newly-referred Migrant People With HIV to BFTAF
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project builds on our experience with the ASAP Study McGill University Health Centre research ethics board MP-37-2020-4911 The goal of this study is to better understand the experience of migrant people with Human Immunodeficiency Virus HIV of having their treatment switched to Bictegraviremtricitabinetenofovir alafenamide BFTAF In other words the investigators want to evaluate how feasible and acceptable this switch is and how participants will take BFTAF fidelity and remain on it The investigators also want to know more about migrant people with HIVs experience of care namely how often they see their HIV specialist or other healthcare professionals and their healthcare coverage the type of insurance that they have
Detailed Description:
International migrants represent an increasing portion of people with HIV in Canada Making sure migrant people with HIV have access to treatment and care is crucial for their health and wellbeing It is also important to make sure that they have a good experience of care and treatment Several treatments exist for HIV and many migrant people with HIV arrive in Quebec with a current or past experience of taking an HIV treatment Sometimes it is a treatment that cannot be continued here for different reasons Thus their treatment must be switched that is changed to another treatment more affordable simpler or more efficient
BFTAF is one HIV treatment BFTAF is simple to take one small-sized pill a day safe highly effective for almost all people with HIV and ideal when one switches from one treatment to another If participants take part in this study their treatment will be switched to BFTAF it will be provided free of charge for the participants
The goal of this study is to better understand the experience of migrant people with HIV of having their treatment switched to BFTAF In other words the investigators want to evaluate how feasible and acceptable this switch is and how participants will take BFTAF fidelity and remain on it The investigators also want to know more about migrant people with HIVs experience of care namely how often they see their HIV specialist or other healthcare professionals and their healthcare coverage the type of insurance that they have
BFTAF is one HIV treatment BFTAF is simple to take one small-sized pill a day safe highly effective for almost all people with HIV and ideal when one switches from one treatment to another If participants take part in this study their treatment will be switched to BFTAF it will be provided free of charge for the participants
The goal of this study is to better understand the experience of migrant people with HIV of having their treatment switched to BFTAF In other words the investigators want to evaluate how feasible and acceptable this switch is and how participants will take BFTAF fidelity and remain on it The investigators also want to know more about migrant people with HIVs experience of care namely how often they see their HIV specialist or other healthcare professionals and their healthcare coverage the type of insurance that they have
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None